Refine your search
Collections
Co-Authors
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Sambath Kumar, R.
- Preterm Birth Facts:A Review
Abstract Views :155 |
PDF Views:0
Authors
Affiliations
1 Department of Pharmacy Practice, JKK Nattraja College of Pharmacy, Komarapalayam, Namakkal (Dist), Tamil Nadu - 638183, IN
2 Department of Pharmaceutics, JKK Nattraja College of Pharmacy, Komarapalayam, Namakkal (Dist), Tamil Nadu - 638183., IN
1 Department of Pharmacy Practice, JKK Nattraja College of Pharmacy, Komarapalayam, Namakkal (Dist), Tamil Nadu - 638183, IN
2 Department of Pharmaceutics, JKK Nattraja College of Pharmacy, Komarapalayam, Namakkal (Dist), Tamil Nadu - 638183., IN
Source
Research Journal of Pharmacy and Technology, Vol 12, No 3 (2019), Pagination: 1383-1390Abstract
Preterm birth is the major complication in neonatal health care that cause death in newborns and also it is the second foremost cause of death in children. It is one of the important complications of neurological disability and impairment. Preterm babies are born before completion of 37 weeks of gestation, instead they born by 32 gestational week. This has several reasons; most preterm birth not only affects the newborns but also family members, to give care for preterm infants. This initiates how they spend several months in hospital and has increasing price for health services. It is estimated worldwide that 11.1% of all live births were born preterm in 2010 (14.9 million babies were born before 37 week of gestation), there is an increasing rate in almost countries with reasonable trend data with preterm. This review had discussed about the majority of factors behind the preterm birth in India. This review may help to prevent the preterm birth by early detection, appropriate intervention, screening for the risk, providing antenatal care, educating the teenage or adolescent pregnant women.Keywords
Preterm Birth, Low Birth Weight, Neonates, Gestation Period.References
- Chythra RR, Lara EE. de Ruiter et al. A Case-Control Study on Risk Factors for Preterm Deliveries in a Secondary Care Hospital, Southern India, ISRN Obstet Gynecol. 2014, 1 (1): 1-5.
- Radhanpuri F et al. Preterm birth and its outcome. Int J Reprod Contracept Obstet Gynecol. 2014;3(1):153-157
- Blencowe H, Cousens S, Chou D, et al. Born Too Soon: The global epidemiology of 15 million preterm births. Reproductive Health. 2013;10(1): 1-2.
- Mavalankar DV, Gray RH, Trivedi CR. Levels and risk factors for perinatal mortality in Ahmadabad, India. Gray Bull World Health Organ. 1991; 69(4): 435–442.
- Mavalankar DV, Gray RH, Trivedi CR. Risk factors for preterm and term low birth weight in Ahmadabad, India. Int J Epidemiol. 1992; 21(2): 263–272.
- Mavalankar DV, Trivedi CR, Gray RH. Maternal weight, height and risk of poor pregnancy outcome in Ahmadabad, India. Indian Pediatr. 1994; 31(10): 1205–1212.
- Dhall K, Bagga R. Maternal determinants of birth weight of north Indian babies. Indian J Pediatr. 1995; 62(3): 333–344.
- Nair NS, Rao RS, Chandrashekar S, Acharya D, Bhat HV. Socio-demographic and maternal determinants of low birth weight: a multivariate approach. Indian J Pediatr. 2000; 67(1): 9–14.
- Sonkusare S, Rai L, Naik P. Preterm birth: mode of delivery and neonatal outcome. Med J Malaysia. 2009; 64(4): 303–306.
- Rao S, Kanade A, Margetts BM, et al. Maternal Activity in Relation to Birth Size in Rural India The Pune Maternal Nutrition Study. Eur J Clin. 2003;57(4):531-542.
- Gupta PC, Sreevidya S. Smokeless tobacco use, birth weight, and gestational age: population based, prospective cohort study of 1217 women in Mumbai, India. BMJ : British Medical Journal. 2004;328(7455):1538.
- Singh Uma, Singh Nisha, Seth Shikha. A prospective analysis of etiology and outcome of preterm labor India., J Obstet Gynecol. 2007; 57(1): 48-52.
- Zhang J, Villar J, Sun W, et al. Blood pressure dynamics during pregnancy and spontaneous preterm birth. Am J Obstet Gynecol . 2007;197(2): 162.e1-162.e6.
- Kumar P, Sankar MJ, Deorari A, Azad R, Chandra P, Agarwal R, Paul V.Risk factors for severe retinopathy of prematurity in preterm low birth weight neonates.Indian J Pediatr. 2011; 78(7): 812–816.
- Bangal, Vidyadhar B et al. A study of risk factors and perinatal outcome in preterm labour at tertiary care hospital. Int J Biomed Sci. 2012; 3(3): 147-150.
- Bellad MB, et al.Consanguinity, prematurity, birth weight and pregnancy loss: a prospective cohort study at four primary health center areas of Karnataka, India. J Perinatol. 2012; 32(6): 431–437.
- Sachin S. Mumbare, Girish Maindarkar, et al, Maternal risk factors associated with term low birth weight neonates: a matched-pair case control study. Indian Pediatr. 2012 Jan; 49(1): 25–28.
- Siddalingappa H, Murthy M.R N, Kulkarni P, N.C A. Prevalence and Factors Influencing Perinatal Mortality in Rural Mysore, India. J Clin Diagn Res. 2013;7(12):2796-2699.
- Siddalingappa H, Murthy M.R N, Kulkarni P, N.C A. Prevalence and Factors Influencing Perinatal Mortality in Rural Mysore, J Clin Diagn Res. 2013;7(12):2796-2699.
- Mayur Bavaliya, Bela Shah, Sucheta Munshi. Study of Risk Factors for Preterm Neonates. IJSR. 2014; 3(1): 9-10.
- Ananya Das, Subrat Panda, Ahanthem SS, Sourabh GD, Bhanu Pratap SG. Preterm Birth: Analysis of Risk Factors and Neonatal Outcome. Obstet Gynecol. 2015; 1 (1): 1-5.
- Nalini et al., Evaluation of risk factors for preterm delivery and creasy’s risk scoring Int J Med Res Health Sci. 2015;4(2):269-273.
- Subha Ranjan, Ipsita Mohapatra, G Sahoo. Study of association of bacterial vaginosis and preterm labour in a tertiary care hospital. Perspectives in Medical Research 2015; 3:3:6-10.
- Padhi BK, Baker KK, Dutta A, et al. Risk of Adverse Pregnancy Outcomes among Women Practicing Poor Sanitation in Rural India: A Population-Based Prospective Cohort Study. Chappell LC, ed. PLoS Medicine. 2015;12(7): e1001851.
- Tamil Selvan et al., A Study of Outcome of Preterm Babies in a Low Resource Hospital, Sch. J. App. Med. Sci. 2015; 3(5D):2082-2084.
- Rather GN, Jan M, Rafiq W, Gattoo I, Hussain SQ, Latief M. Morbidity and Mortality Pattern in Late Preterm Infants at a Tertiary Care Hospital in Jammu & Kashmir, Northern India. J Clin Diagn Res. 2015;9(12):1-4.
- Govindaraju P, Venugopal S, Shivakumar MA, Sethuraman S, Ramaiah SK, Mukundan S. Maternal periodontal disease and preterm birth: A case-control study. J. Indian Soc. Periodontol. 2015;19(5):512-515.
- Mukhopadhyay P, Chaudhuri RN, Paul B. Hospital-based Perinatal Outcomes and Complications in Teenage Pregnancy in India. J Health Popul Nutr. 2010;28(5):494-500.
- Tellapragada C, Eshwara VK, Bhat P, et al. Risk Factors for Preterm Birth and Low Birth Weight Among Pregnant Indian Women: A Hospital-based Prospective Study. J Prev Med. 2016;49(3):165-175.
- Soni A, Kadam S, Pandit A, Patole S. Early Discharge of Preterm Infants- An Indian Perspective. J Clin Diagn Res. 2016;10(12):21-23.
- Rashmi A et al., Risk factors for preterm birth: a community based longitudinal study in rural Mysuru, Karnataka, India. Int J Community Med Public Health. 2016 Dec;3(12):3576-3580
- Kuppusamy N, Vidhyadevi A. Prevalence of Preterm Admissions and the Risk Factors of Preterm Labor in Rural Medical College Hospital. Int J Sci Stud 2016;4(9):125-128.
- Rao D, Kumar S, Mohanraj R, Frey S, Manhart LE, L Kaysen D. The impact of domestic violence and depressive symptoms on preterm birth in South India. Soc Psychiatr Epidemiol. 2016 ;51(2):225-232.
- Dutta, et al. Stress in Fathers of Premature Newborns Admitted in a Neonatal Intensive 1Care Unit. Indian Pediatr. 2016;53(4):311-313.
- Surve MV, Anil A, Kamath KG, et al. Membrane Vesicles of Group B Streptococcus Disrupt Feto-Maternal Barrier Leading to Preterm Birth. Sullam PM, ed. PLoS Pathogens. 2016;12(9):e1005816.
- Ahankari A, Bapat S, Myles P, Fogarty A, Tata L. Factors associated with preterm delivery and low birth weight: a study from rural Maharashtra, India. F1000Research. 2017; 6:72.
- Mahajan A, Magon S. Study of risk factors for preterm births in a teaching hospital: A prospective study. Int J Med and Dent Sci 2017;6(1):1407-1412.
- Walia M, Saini N. Relationship between periodontal diseases and preterm birth: Recent epidemiological and biological data. Int J Appl Basic Med Res. 2015;5(1):2-6.
- Govindaraju P, Venugopal S, Shivakumar MA, Sethuraman S, Ramaiah SK, Mukundan S. Maternal periodontal disease and preterm birth: A case-control study. J Indian Soc. Periodonal. 2015;19(5):512-515.
- Rao KS, Ramya KS, Batchu D, et al. Teenage pregnancy and its obstetric outcome. J. Evid. Based Med. Healthc. 2017; 4(15), 901-904.
- A Review on the Effect of Immunosuppressants on Fertility
Abstract Views :135 |
PDF Views:0
Authors
Affiliations
1 Department of Pharmacy Practice, J.K.K. Nattraja College of Pharmacy, Komarapalayam-638183, Tamil Nadu, IN
2 Department of Pharmacology, J.K.K. Nattraja College of Pharmacy, Komarapalayam-638183, Tamil Nadu, IN
3 Department of Pharmaceutics, J.K.K. Nattraja College of Pharmacy, Komarapalayam-638183, Tamil Nadu, IN
1 Department of Pharmacy Practice, J.K.K. Nattraja College of Pharmacy, Komarapalayam-638183, Tamil Nadu, IN
2 Department of Pharmacology, J.K.K. Nattraja College of Pharmacy, Komarapalayam-638183, Tamil Nadu, IN
3 Department of Pharmaceutics, J.K.K. Nattraja College of Pharmacy, Komarapalayam-638183, Tamil Nadu, IN
Source
Research Journal of Pharmacy and Technology, Vol 12, No 3 (2019), Pagination: 1441-1447Abstract
Background: Infertility is defined as not being able to get pregnant (conceive) after one year (or longer) of unprotected sex. Many studies had showed that extensive use of immunosuppressant’s may result in infertility. Immunosuppressive drugs are used in the treatment of inflammatory and autoimmune diseases, as well as in transplantation. Frequently prescribed in young people, these treatments may have deleterious effects on fertility, pregnancy outcomes and the unborn child. Aim: The aim of this study is to review the literatures depicting the about immunosuppressant’s, its impact on fertility and related pregnancy outcomes. Methods: A systematic literature search of the Pub Med database was performed using a combination of relevant terms related to ‘infertility’, 'conception', 'reproduction', 'immunosuppressant’s. Conclusion: From the review of many literatures this study concludes that immunosuppressants has varying effect on pregnancy. Some of the immunosuppressants at therapeutic doses can cause infertility when used for a long time.Keywords
Fertility, Reproduction, Conception, Immunosuppressants.References
- Kumar R. Male infertility–Current concepts. Indian Journal of Urology : IJU : Journal of the Urological Society of India. 2011, 27(1):39-40. doi:10.4103/0970-1591.78419.
- Smith S, Pfeifer SM, Collins JA. Diagnosis and management of female infertility. JAMA. 2003; 290(13): 1767-1770.
- Doherty CM, Clark MM. Infertility treatment. 1st ed. Czech Republic: Computer Press Brno; 2006; 1-121.
- Gleicher N, Barad D. Unexplained infertility: does it really exist? Hum Reprod. 2006; 21(8): 1951-1955.
- Iiristatidis C, Bhattacharya S. Unexplained infertility: does it really exist? Does it matter? Hum Reprod. 2007; 22(8): 2084-2087.
- Brazdova A. Study of immunological properties of sperm and seminal plasma antigens: anti-seminal and anti-sperm antibodies in female immune infertility. Characterization of targeted proteins. Presented for the Ph.D., Paris. Pierre and Marie Curie university. 2014.
- Crosignani PC, Collins J, Cooke ID, Diczfalusy E, Rubin B. Recommendations of the ESHRE workshop on 'Unexplained Infertility'. Anacapri, August 28-29, 1992. Hum Reprod. 1993; 8(6): 977-980.
- Hisatomi A, Fujihira S, Fujimoto Y, Fujii T. Effect of Prograf (FK506) on spermatogenesis in rats.Toxicology.1996; 109(3):75-83.
- Rovira J, Diekmann F, Ramírez M. Campistol. Sirolimus-associated testicular toxicity: detrimental but reversible. Transplantation,2012; 93: 874-879.
- Masuda H, Fujihira S, Ueno H, Kagawa H, Katsuoka M. Ultrastructural study on cytotoxic effects of cyclosporine A in spermiogenesis in rats. Medical Electron Microscopy,2003; 36: 183-191.
- Leroy et al. Immunosuppressive drugs and infertility.Orphanet Journal of Rare Diseases .2015; 10:136.
- Sands K, Jansen R, Zaslau S, Greenwald D. Review article: the safety of therapeutic drugs in male inflammatory bowel disease patients wishing to conceive. Aliment Pharmacol Ther 2015; 41:821-834.
- Taffet SL, Das KM. Sulfasalazine. Adverse effects and desensitization.Dig Dis Sci 1983; 28: 833-842.
- O'Moráin C, Smethurst P, Doré CJ, Levi AJ. Reversible male infertility due to sulphasalazine: studies in man and rat. Gut 1984; 1078-1084.
- Birnie GG, McLeod TI, Watkinson G. Incidence of sulphasalazineinduced male infertility. Gut 1981; 22: 452-455.
- Moody GA, Mayberry JF. Perceived sexual dysfunction amongst patients with inflammatory bowel disease. Digestion 1993; 54: 256-260.
- Toovey S, Hudson E, Hendry WF, Levi AJ. Sulphasalazine and male infertility: reversibility and possible mechanism. Gut 1981; 22:445-451.
- Fukushima T, Hamada Y, Komiyama M, Matsuno Y, Mori C, Horii. Early changes in sperm motility, acrosome reaction, and gene expression of reproductive organs in rats treated with sulfasalazine. Reprod Toxicol 2007; 23: 153-157.
- Alonso V, Linares V, Bellés M, Albina ML, Sirvent JJ, Domingo JL, Sánchez DJ. Sulfasalazine induced oxidative stress: a possible mechanism of male infertility. Reprod Toxicol 2009; 27: 35-40.
- Linares V, Alonso V, Domingo JL. Oxidative stress as a mechanism underlying sulfasalazine-induced toxicity. Expert Opin Drug Saf 2011; 10: 253-263.
- Wu FC, Aitken RJ, Ferguson A. Inflammatory bowel disease and male infertility: effects of sulfasalazine and 5-aminosalicylic acid on sperm-fertilizing capacity and reactive oxygen species generation. Fertil Steril 1989; 52: 842-845.
- Hultén L. Proctocolectomy and ileostomy to pouch surgery for ulcerative colitis. World J Surg 1998; 22: 335-341.
- Cosentino MJ, Chey WY, Takihara H, Cockett AT. The effects of sulfasalazine on human male fertility potential and seminal prostaglandins. J Urol 1984; 132: 682-686.
- Riley SA, Lecarpentier J, Mani V, Goodman MJ, Mandal BK, Turnberg LA. Sulphasalazine induced seminal abnormalities in ulcerative colitis: results of mesalazine substitution. Gut 1987; 28:1008-1012.
- Chatzinoff M, Guarino JM, Corson SL, Batzer FR, Friedman LS. Sulfasalazine-induced abnormal sperm penetration assay reversed on changing to 5-aminosalicylic acid enemas. Dig Dis Sci 1988; 33:108-110.
- Zelissen PM, van Hattum J, Poen H, Scholten P, Gerritse R, te Velde ER. Influence of salazosulphapyridine and 5-aminosalicylic acid on seminal qualities and male sex hormones. Scand J Gastroenterol 1988; 23: 1100-1104.
- Chermesh I, Eliakim R. Mesalazine-induced reversible infertility in a young male. Dig Liver Dis 2004; 36: 551-552.
- Shin T, Kobori Y, Suzuki K, Iwahata T, Yagi H, Soh S, Arai G, Okada H. Inflammatory bowel disease in subfertile men and the effect of mesalazine on fertility. Syst Biol Reprod Med 2014; 60: 373-376.
- Drobnis E.Z., Nangia A.K. (2017) Immunosuppressants and Male Reproduction. In: Impacts of Medications on Male Fertility. Advances in Experimental Medicine and Biology, vol 1034. Springer, Cham.
- Aguilar-Mahecha A, Hales BF, Robaire B. Chronic cyclophosphamide treatment alters the expression of stress response genes in rat male germ cells. Biol Reprod. 2002;66:1024–1030.
- Connell WR, Kamm MA, Ritchie JK, Lennard-Jones JE. Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience. Gut 1993;34:1081–1085.
- Conell WR, Kamm MA, Dickson M, Balkwill AM, Ritchie JK, Lennard-Jones JE. Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease. Lancet 1994;342:1249– 1252.
- Korelitz BI, Mirsky FJ, Fleisher MR, Warman JI, Wisch N, Gleim GW. Malignant neoplasms subsequent to treatment of inflammatory bowel disease with 6-mercaptopurine. Am J Gastroenterol 1999;94:3248–3253.
- Sulfasalazine or mesalamine, glucocorticoids, and immunosuppressive drugs such as azathioprine (AZA) or 6-mercaptopurine (6-MP) are accepted as standard therapies in IBD.
- Podolsky DK. Inflammatory bowel disease (second of two parts). N Engl J Med 1991;325:1008–1016. Rutgeerts P. Medical therapy of inflammatory bowel disease. Digestion 1998;59:453–469.
- Korelitz BI, Present DH. Favorable effect of 6-mercaptopurine on the fistulae of Crohn’s disease. Dig Dis Sci 1985;30:58–64.
- O’Brian JJ, Bayless TM, Bayless JA. Use of azathioprine or 6-mercaptopurine in the treatment of Crohn’s disease. Gastroenterology 1991;101:39–46.
- Connell WR, Kamm MA, Ritchie JK, Lennard-Jones JE. Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience. Gut 1993;34:1081–1085.
- Conell WR, Kamm MA, Dickson M, Balkwill AM, Ritchie JK, Lennard-Jones JE. Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease. Lancet 1994;342:1249– 1252.
- Korelitz BI, Mirsky FJ, Fleisher MR, Warman JI, Wisch N, Gleim GW. Malignant neoplasms subsequent to treatment of inflammatory bowel disease with 6-mercaptopurine. Am J Gastroenterol 1999;94:3248–3253.
- Kim PS, Zlatanic J, Korelitz BI, Gleim GW. Optimum duration of treatment with 6-mercaptopurine for Crohn’s disease. Am J Gastroenterol 1999;94:3254–3257.
- Lewis JD, Schwartz JS, Lichtenstein GR. Azathioprine for maintenance of remission in Crohn’s disease: benefits outweigh the risk of lymphoma. Gastroenterology 2000;118:1018–1024.
- Voogd CE. Azathioprine, a genotoxic agent to be considered non-genotoxic in man. Mutat Res 1989;221:133–152.
- Brown JH, Maxwell AP, McGeown MG. Outcome of pregnancy following renal transplantation. Ir J Med Sci 1991;160:255–256.
- Haugen G, Fauchald P, Sodal G, Leivestad T, Moe N. Pregnancy outcome in renal allograft recipients in Norway. The importance of immunosuppressive drug regimen and health status before pregnancy. Acta Obstet Gynecol Scand 1994;73:541–546.
- Alstead EM, Ritchie JK, Lennard-Jones JE, Farthing MJ, Clark ML. Safety of azathioprine in pregnancy in inflammatory bowel disease. Gastroenterology 1990;99:443–446.
- Modigliani R. Drug therapy for ulcerative colitis during pregnancy. Eur J Gastroenterol Hepatol 1997;9:854–857.
- Marion JF. Toxicity of 6-mercaptopurine/azathioprine in patients with inflammatory bowel disease. Inflamm Bowel Dis 1998;4: 116–117.
- Karbach U, Ewe K, Schramm P. Quality of semen in patients with Crohn’s disease. Z Gastroenterol 1982;20:314–320.
- Farthing MJ, Dawson AM. Impaired semen quality in Crohn’s disease-drugs, ill health, or undernutrition? Scand J Gastroenterol 1983;18:57–60.
- Narendranathan M, Sandler RS, Suchindran CM, Savitz DA. Male infertility in inflammatory bowel disease. J Clin Gastroenterol 1989;11:403–406.
- Rajapakse RO, Korelitz BI, Zlatanic J, Baiocco PJ, Gleim GM. Outcome of pregnancies when fathers are treated with 6-mercaptopurine for inflammatory bowel disease. Am J Gastroenterol 2000;95:684–688.
- Kane SV. What’s good for the goose should be good for the gander-6-MP use in fathers with inflammatory bowel disease. Am J Gastroenterol 2000;95:581–582
- Narendranathan M , Sandler RS , Suchindran CM , Savitz DA . Male infertility in inflammatory bowel disease. Journal of Clinical Gastroenterology.1989, 11(4):403-406.
- Laren JF, Burney Ro, Milki AA, Westphal LM. Effect of methotrexate exposure on subsequent fertility in women undergoing controlled ovarian stimulation. Fertil steril.2009; 92(2): 515-519.
- Etherington J, Mootoo R, Mathews JA. An audit of the outpatient use of disease modifying and immunosuppressive anti-rheumatic drugs. Br J Rheum.1995; 34(1): 100-103.
- Angier RB, Boothe JW, Hutchings BL. The structure and synthesis of the liver L. Casei factor. Science.1946; 103(1): 667-669.
- Seger DR, Smith JM Jr, Haltquist ME. Antagonist for pteroylglutamic acid. J Am Chem Soc.1947; 69(4):2567.
- Farber S, Diamond LK, Mercer RD, Sylvester RF Jr, Soliff JA. Temporary remission in acute leukaemia in children produced by folic antagonist 4-aminopteroyl-glutamic acid (aminopterin) .N Engl J Med.1948; 238: 787-793.
- Goldin A. Preclinical methodology for the selection of anticancer agents. In Busch H, ed. Methods in Cancer Research, vol IV. New York, Academic Press, 1968:193–254.
- AHFS Drug Information.1999;751-759.
- Gunther E. Andrologic examinations in the antimetabolite therapy of psoriasis. Dermatol Monatsschr 1970;156: 498-502.
- Grunnet E, Nyfors A, Hansen KB. Studies of human semen in topical corticosteroid–treated and in methotrexate-treated psoriatics. Dermatologica 1977;154:78-84.
- De Luca M, Ciampo E, Rossi A. Study of the seminal fluid in subjects treated with methotrexate. G Ital Dermatol Minerva Dermatol 1971;46:247-249.
- Bacci G, Ferrari S, Bertoni F, Ruggieri P, Picci P, Longhi A, et al. Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli/osteosarcoma-2 p -2 protocol: an updated report. J Clin Oncol 2000;18:4016-4027.
- Siimes MA, Elomaa I, Koskimies A. Testicular function after chemotherapy for osteosarcoma. Eur J Cancer 1990;26:973-975.
- Yeuhi chen et al. Long-Term Impact of Immunosuppressants at Therapeutic Doses on Male Reproductive System in Unilateral Nephrectomized Rats: A Comparative Study. BioMed Research International. 2013; 2: 1-9.
- Nakawaga et al. Immunosuppression with tacrolimus improved reproductive outcome of women with repeated implantation failure and elevated peripheral blood TH1/TH2 cell ratios. Am J Reprod Immunol. 2015; 73(4):353-361.
- A Review on Relevance of Herbal Medications for Psychiatric Patients
Abstract Views :374 |
PDF Views:0
Authors
Affiliations
1 Pharm D Intern, J. K. K. Nattraja College of Pharmacy, Kumarapalayam, 638183, Erode, Tamil Nadu, IN
2 Department of Pharmacy Practice, J. K. K. Nattraja College of Pharmacy, Kumarapalayam 638183, Erode, Tamil Nadu, IN
3 Department of Pharmaceutics, J. K. K. Nattraja College of Pharmacy, Kumarapalayam 638183, Erode, Tamil Nadu, IN
1 Pharm D Intern, J. K. K. Nattraja College of Pharmacy, Kumarapalayam, 638183, Erode, Tamil Nadu, IN
2 Department of Pharmacy Practice, J. K. K. Nattraja College of Pharmacy, Kumarapalayam 638183, Erode, Tamil Nadu, IN
3 Department of Pharmaceutics, J. K. K. Nattraja College of Pharmacy, Kumarapalayam 638183, Erode, Tamil Nadu, IN
Source
Research Journal of Pharmacy and Technology, Vol 12, No 7 (2019), Pagination: 3151-3156Abstract
Objective: This review illustrates on the use of herbal medication and its impact among psychiatric patients. Method: PubMed was searched for articles related to the herbal remedies used in the psychiatric patients. A secondary search was performed using references obtained from articles published from 2000 – 2017 identified by the PubMed search. Articles focusing on the experimental trails in adults and those patients who were not on medication was excluded during the selection process and those articles which aimed in accessing the incidence of drug interaction and possible negative effects due to co-administration of herbal medications with psychiatry drugs was included in this review. Result and Discussion: Effective studies have shown that additional alternative treatment with particularized herbal medicine increases antidepressant response and that reduces certain side effects associated with psychotropic medications. Herbal medicines used for the treatment of psychiatric problems was produced safe and effective towards severe depressive episodes, but usage of these herbal drugs in patients with mental illness led to unusual occurrence of side effects. This review also discusses the pharmacological mechanism of drug interaction of various herbal medications. Conclusion: This review gives an insight of the importance in increasing the knowledge of the health care professionals of the safety and efficacy of psychiatric drug use with herbal medication, at the same time it is also important to provide information to the patients regarding the benefits and contraindications of these herbal remedies when accessed with the other psychiatric medications.Keywords
Herbal Remedies, Psychiatry, Gamma‐Aminobutyric Acid (GABA), Dopamine (DA), Noradrenalin (NA), Serotonin (5-HT), Central Nervous System (CNS).References
- Tomasz S. Herbal remedies in depression – state of the art. Psychiatry. 2014; 48(1): 59–73.
- Siu WT, Wayne HT, Brian EL. Herbal medicine for psychiatric disorders: Psychopharmacology and neuroscience-based nomenclature. World Journal of Biological Psychiatry. 2017; 10(1): 1-6
- Jerome S. Herbal medicines in the treatment of psychiatric disorders. Phytotherapy Research. 2018;21(8):1–16
- Noosha N, Jess PS, Alison BH, et al. The Use of Herbal Medications and Dietary Supplements by People with Mental Illness. Community Mental Health Journal. 2010; 46(1):563–569.
- Gabrielle B, Gregory EG. A Review of Herbal Medicines for Psychiatric Disorders. Psychiatric Services. 2000; 51(9): 1130-1134.
- Liu LY, Feng B, Chen J, Tan QR, et al. Herbal medicine for hospitalized patients with severe depressive episode: a retrospective controlled study. Journal of Affective Disorders. 2015; 170(5):71-77.
- Gałuszko M, Cubała WJ. Rola dziurawca w leczeniu depresji. Psychiatria. 2005, 2(2):93–96.
- Shahmansouri N, Farokhnia M, Abbasi SH, Kassaian SE, Noorbala Tafti AA, Gougol A i wsp. A randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous coronary intervention patients. Journal of Affective Disorders. 2013; 155(7):216–222.
- Modabbernia A, Sohrabi H, Nasehi AA, et al. Effect of saffron on fluoxetine-induced sexual impairment in men: randomized double-blind placebo-controlled trial. Psychopharmacology. 2012; 223(4): 381–388.
- Kunnumakkara AB, Bordoloi, D, Padmavathi G, et al. Curcumin, the golden nutraceutical: Multitargeting for multiple chronic diseases. British Journal of Pharmacology.2017;174:1325–1348.
- Berk M, Williams LJ, Jacka FN. So depression is an inflammatory disease, but where does the inflammation come from. BMC Medicine.2013;11:197-200.
- Yu JJ, Pei LB, Zhang Y, Wen ZY, Yang JL. Chronic supplementation of curcumin enhances the efficacy of antidepressants in major depressive disorder: A randomized, double‐blind, placebo‐controlled pilot study. Journal of Clinical Psychopharmacology.2015; 35: 406–410.
- Akhondzadeh S, Kashani L, Fotouhi A, Jarvandi S, Mobaseri M, Moin M i wsp. Comparison of lavandula angustifolia mill. tincture and imipramine in the treatment of mild to moderate depression: a double-blind, randomized trial. Progress in Neuropsychopharmacology and Biological Psychiatry. 2003;27(1):123–127.
- Sayyah M, Sayyah M, Kamalinejad M. A preliminary randomized double blind clinical trial on the efficacy of aqueous extract of Echium amoenum in the treatment of mild to moderate major depression. Progress in Neuropsychopharmacology and Biological Psychiatry. 2006;30(1):166–169
- Ishaque S, Shamseer L, Bukutu C, Vohra S. Rhodiola rosea for physical and mental fatigue: a systematic review. BMC Complementory and Alternative Medicine. 2012;12(4):70.
- Brown RP, Gerbarg PI, Ramozanowv Z. Rhodiola rosea: A phytomedicinal overview. HerbalGram. 2002;56(3):40–52.
- Amsterdam JD, Shults J, Soeller I, Mao JJ. Chamomile (Matricaria recutita) may provide antidepressant activity in anxious, depressed humans: an exploratory study. Alternative Therapies in Health and Medicine. 2012;18(5):44–49.
- Wiklund IK, Mattsson LA, Lindgren R, Limoni C. Effects of a standardized ginseng extract on quality of life and physiological parameters in symptomatic postmenopausal women: a double-blind, placebo-controlled trial. Swedish Alternative Medicine Group. International Journal of Clinical Pharmacolgy Research. 1999;19(7):89–99.
- Jussofie A, Schmiz A, Hiemke C. Kavapyrone enriched extract from Piper methysticum as modulator of the GABA binding site in different regions of rat brain. Psychopharmacology. 1994;116:469–474.
- Seitz U, Schule A, Gleitz J. [3H]-monoamine uptake inhibition properties of kava pyrones. Planta Medica.1997;63:548–549
- Gleitz J, Friese J, Beile A, et al. Anticonvulsive action of (+/–)-kavain estimated from its properties on stimulated synaptosomes and Na+ channel receptor sites. European Journal of Pharmacology.1996; 315:89–97.
- Schultz V, Hansel R, Tyler VE: Rational Phytotherapy: A Physician’s Guide to Herbal Medicine. Berlin, Springer-Verlag, 1998.
- Kleijnen J, Knipschild P. Ginkgo biloba. Lancet.1992;340:1136–1139.
- Chan TY, Tang CH, Critchley JA. Poisoning due to an over-the-counter hypnotic, Sleep-Qik (hyoscine, cyproheptadine, valerian). Postgraduate Medical Journal.1995; 71:227–228.
- Charles PD, Ambigapathy G, Geraldine P, Akbarsha MA, Rajan, KE. Bacopa monniera leaf extract up‐regulates tryptophan hydroxylase (TPH2) and serotonin transporter (SERT) expression: Implications in memory formation. Journal of Ethnopharmacology.2010;134(1):55-61
- Singh HK, Dhawan BN. Neuropsychopharmacological effects of the ayurvedic nootropic Bacopa monniera Linn. (Brahmi). Indian Journal of Pharmacology.1997; 29:359–365.
- Stough C, Lloyd J, Clarke J, et al. The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects. Psychopharmacology. 2001;156: 481–484.
- Andrew S, Amy G, Chris N, et al. Anti-Stress Effects of Lemon Balm-Containing Foods. Nutrients.2014;6(3):4805-4821.
- Chandrasekhar K, Jyoti K, Sridhar A. A Prospective, Randomized Double-Blind, Placebo-Controlled Study of Safety and Efficacy of a High-Concentration Full-Spectrum Extract of Ashwagandha Root in Reducing Stress and Anxiety in Adults. Indian Journal of Psychological Medicine.2012;34(3):255–262.
- Elsasa M, Rossib DJ, Raber J, et al. Passiflora incarnata L. (Passionflower) extracts elicit GABA currents in hippocampal neurons in vitro, and show anxiogenic and anticonvulsant effects in vivo, varying with extraction method. Phytomedicine. 2010; 17(12): 940–949.